Teva Pharmaceutical Industries Limited · TASE:TEVA
Teva Pharmaceutical Industries — Investor Day (October 2007)
7 slides from Teva Pharmaceutical Industries's investor day presentation, Oct 15, 2007
Slide 1: Itzhak Krinsky, Corporate Vice President - Business Development
Itzhak Krinsky, Ph.D Corporate Vice President - Business Development October 15, 2007 1 Forward-Looking Statements TODAY’S PRESENTATION CONTAINS FORWARD LOOKING STATEMENTS WHICH EXPRESS THE CURRENT BELIEFS AND EXPECTATIONS OF MANAGEMENT. SUCH STATEMENTS ARE BASED ON CURRENT EXPECTATIONS AND INVOLVE
Slide 2: Business Development Arena
Business Development Arena Key Generic M&A by Region 2004-2006 3 Business Development Arena • Business Development is one of Teva’s core competencies ¾ Expertise in acquiring companies and extracting synergies ¾ Skilled at identifying partners and negotiating strategic partnerships • Business Develo
Slide 3: Corporate Business Development Leads the Following Processes
Corporate Business Development Leads the Following Processes ¾ M&A’s, equity investments and JV’s at all level regardless of deal scale ¾ Transactions with implications across / beyond geographical groups ¾ Transactions concerning innovative products ¾ Transactions with scale beyond $10 MM All the a
Slide 4: What Defines a Viable Candidate? The Acquisition Process
What Defines a Viable Candidate? ¾ Strategic fit ¾ Support leadership position ¾ Profitable growth ¾ Significant synergies with existing Teva organization ¾ Financially justified on a DCF basis, ROIC, etc. ¾ Accretive to EPS within a reasonable time 7 The Acquisition Process I. Targeting II. Evaluat
Slide 5: The Acquisition Process: Phase I and Phase II-III
The Acquisition Process: Phase I Investment Market Consultants Bankers Intelligence Teva Business Industry Units contacts Business Development Internal Analysis 9 The Acquisition Process: Phase II-III Offering Memorandum Corporate Business Development R&D Markets Finance Bankers Operations Legal/IP
Slide 6: The Acquisition Process: Phase IV
The Acquisition Process: Phase IV ¾ Business units are responsible for integration and on -going management ¾ Create management commitment through acquisition model ¾ Adaptation of integration plan by acquired unit – make it “their plan” 11 The Acquisition Process: Phase IV (Cont’) ¾ Clear leadershi
Slide 7: Tips for Acquirers; Some Key Lessons of Business Development
Tips for Acquirers ¾ Robust analysis of synergy and performance targets ¾ Identify and investigate post deal issues prior to completion- these can be deal breakers ¾ Use regulatory period to start post deal management work ¾ Set up dedicated management team to manage the post deal work ¾ Obtain cont
Teva Pharmaceutical Industries — Investor Day (October 2007) on 6ix